What a model: A newly developed pancreatic murine cell line permissive to adenoviral replication

Mol Ther Oncol. 2025 Mar 13;33(1):200956. doi: 10.1016/j.omton.2025.200956. eCollection 2025 Mar 20.

Manlio Fusciello^{1

2

3

4}, Vincenzo Cerullo^{1

2

3

4

5}

¹ Drug Research Program (DRP), ImmunoViroTherapy Lab (IVT), Division of Pharmaceutical Biosciences, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5E, 00790 Helsinki, Finland.
² Helsinki Institute of Life Science (HiLIFE), University of Helsinki, Fabianinkatu 33, 00710 Helsinki, Finland.
³ Translational Immunology Program (TRIMM), Faculty of Medicine Helsinki University, University of Helsinki, Haartmaninkatu 8, 00290 Helsinki, Finland.
⁴ Digital Precision Cancer Medicine Flagship (iCAN), University of Helsinki, 00014 Helsinki, Finland.
⁵ Department of Molecular Medicine and Medical Biotechnology and CEINGE, Naples University Federico II, 80131 Naples, Italy.

No abstract available

Publication types